Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Microbia PE Bolsters Senior Management Team; Positions Company for Commercializing Proprietary Bioproducts
Date:12/17/2008
ate & Lyle Investments, Ltd. Microbia was established in 2006 as a majority-owned subsidiary of Ironwood Pharmaceuticals, Inc. and is based in Lexington, Massachusetts.
Contact:
Mary Moynihan
M2Friend Biocommunications
802.951.9600
mary@m2friend.com
'/>"/>
| SOURCE Microbia Precision Engineering, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. New Online Tutorial for the Comprehensive Microbial Resource (CMR)
2. PURE Bioscience and Ciba Strike New Contract for Natural Antimicrobial
3. Celsis Launches RapiScreen(TM) Beverage Microbial Screening System
4. Peramivir Phase 2 Data for the Treatment of Outpatient Influenza to be Presented at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
5. 90 billion tons of microbial organisms live in the deep biosphere
6. Microtest Labs Doubles Microbial Identification, Analytical Services
7. Advanced Analytical Unveils New Instrument for Rapid Microbial Identification at BIO 2008
8. Microbia Announces Name Change to Ironwood Pharmaceuticals
9. New Microbial Genome-to-Array Service
10. Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S.
11. Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular Technology
Post Your Comments:
(Date:5/17/2013)... RESEARCH TRIANGLE PARK, N.C., USA (PRWEB) May 17, 2013 ... Green Globes Certified for sustainability , ... drought and insect pressures , Syngenta ... grand opening celebration today at the company’s RTP Innovation ... Crop Lab allows company researchers to simulate any agricultural ...
(Date:5/17/2013)... ALTO, Calif. , May 17, 2013 /PRNewswire/ ... it has achieved 50% enrollment of the total ... to evaluate the safety and preliminary efficacy of ... Cells) therapy for Knee Osteoarthritis (KOA). To date ... (SAE) reported. The Phase I open ...
(Date:5/17/2013)... May 17, 2013 /PRNewswire-iReach/ -- Aridis is pleased ... with Switzerland -based Kenta Biotech ... monoclonal antibody (mAb) products, and technologies. This asset ... for treatment of infections by common pathogens including ... , Pseudomonas aeruginosa , Acinetobacter baumannii ...
(Date:5/17/2013)... May 17, 2013 Men’s skin is biologically ... La-roche Posay ) and has been known to react more ... men may be far from puberty, other acne causing factors ... causing breakouts, and threatening skin with unsightly acne scars. Adult ... Men’s Health on how to reduce and prevent ...
Breaking Biology Technology:Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2[0] Syngenta Opens Unique $72 Million Advanced Crop Lab[0] Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis[0] Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech[0] Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It
... A new Hospital Energy Performance Service ... energy efficiency by 25% or more ... low-cost modifications. The service is available from ... Massachusetts-based environmental and engineering consulting firm."Healthcare facilities are heavy energy ...
... particle (VLP) vaccine progresses with study designed to select ... Novavax, Inc. (Nasdaq: NVAX ) announced ... trial of its virus-like particle (VLP) seasonal influenza vaccine. ... II randomized, placebo controlled clinical trial has been designed ...
... May 5 Novagali Pharma, a French,pharmaceutical ... New Drug Application (IND) to conduct a ... the treatment of glaucoma has been,granted by ... Catioprost(R) is a,topical ocular proprietary BAK-free formulation ...
Cached Biology Technology:New Hospital Energy Performance Service Helps Hospitals Cut Energy Costs by 25% or More 2Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate 2Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate 3Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate 4Novagali Pharma Announces FDA Clearance of IND for Phase III of Catioprost(R), its Cationic Emulsion of Latanoprost in Patients With Glaucoma 2New Hospital Energy Performance Service Helps Hospitals Cut Energy Costs by 25% or MoreNovavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine CandidateNovagali Pharma Announces FDA Clearance of IND for Phase III of Catioprost(R), its Cationic Emulsion of Latanoprost in Patients With Glaucoma
(Date:5/17/2013)... An international team of scientists ... and cell movement inside a living frog embryo in ... new method to advance biological research and the search ... University and the Karlsruher Institut fr Technologie in Germany, ... U.S. Department of Energy,s Argonne National Laboratory, released the ...
(Date:5/16/2013)... a fast food restaurant had a higher body mass ... fast food, according to researchers at The University of ... particularly strong among those with a lower income. ... American Journal of Public Health indicates higher BMI ... and among lower-income African-Americans, the density, or number, of ...
(Date:5/16/2013)... layer lining the body,s blood vessels, is extremely ... thickness, this super-tenuous structure routinely withstands blood flow, ... a unique and highly dynamic barrier that maintains ... body,s circulatory system. , It,s also extremely adaptable. ... breached to enable immune cells to reach ...
Breaking Biology News(10 mins):New X-ray method shows how frog embryos could help thwart disease 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4... of California, San Diego biologists and their colleagues have ... repair of insect cuticle--the outer layer of the body ... a finding that could lead to new insights into ... The UCSD biologists' study, published April 15 in the ...
... knee, and other joint replacements, according to research published ... by researchers at the University of California, San Diego ... Engineering. The team demonstrated that titanium implants are safe ... and tear can generate micrometer-sized particles. , "As replacement ...
... discovered a fascinating symbiotic relationship between a wasp ... relationship that potentially sheds light on how bacteria ... defensive mechanisms against other microbes. In the new ... the European beewolf, harbors Streptomyces bacteria in unique ...
Cached Biology News:Master gene controls healing of skin in fruit flies and mammals 2Master gene controls healing of skin in fruit flies and mammals 3UCSD medical/bioengineering reseachers show titanium debris satobtage artificial joints 2Symbiotic bacteria protect hunting wasps from fungal infestation 2Rabbit polyclonal to VEZT ( Abpromise for all tested applications). Antigen: Full length human VEZT conjugated to GST Entrez Gene ID: 55591 Swiss Protein ID: Q9HBM0...
AADAC Immunogen: AADAC (NP_001077, 201 a.a. ~ 301 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Mouse monoclonal [CIa] to Ia Antigen (Biotin) ( Abpromise for all tested applications)....
Goat polyclonal to FBXO2 ( Abpromise for all tested applications). entrezGeneID: 26232 SwissProtID: Q9UK22...
Biology Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |